MEDX Among Health Care ETFs
End-of-day Nov 18, 2026 · 33 Health care ETFs by YTD
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.4% | −4.1% | −0.3% | −1.0% | +10.4% | +13.1% | +44.0% | — | — | +28.6% |
| Peer average | −0.9% | −5.3% | −1.4% | −2.4% | +17.0% | +21.8% | +68.8% | +23.4% | +169.9% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$215 of every $1,000 in MEDX is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYEli Lilly | Healthcare | 21.49% | $2,148.61 | 2,654 | $3.8M |
| 2 | ABBVAbbVie | Healthcare | 10.16% | $1,016.20 | 6,068 | $1.8M |
| 3 | —US Bank Mmda - Usbgfs 7 06/01/2031 | — | 7.89% | $789.35 | 1.4M | $1.4M |
| 4 | NVSNovartis AG | Healthcare | 6.90% | $690.03 | 7,582 | $1.2M |
| 5 | JNJJohnson & Johnson | Healthcare | 6.05% | $605.37 | 3,798 | $1.1M |
| 6 | AMGNAmgen | Healthcare | 4.88% | $488.18 | 1,864 | $854K |
| 7 | ALKSAlkermes | Healthcare | 4.73% | $473.03 | 18K | $827K |
| 8 | AZNAstraZeneca | Healthcare | 4.73% | $472.53 | 4,533 | $826K |
| 9 | MRKMerck | Healthcare | 4.35% | $435.23 | 5,308 | $761K |
| 10 | BMYBristol-Myers Squibb | Healthcare | 4.19% | $418.80 | 12K | $732K |
| 11 | BIIBBiogen | Healthcare | 3.53% | $353.41 | 2,464 | $618K |
| 12 | PFEPfizer | Healthcare | 3.33% | $333.33 | 20K | $583K |
| 13 | REGNRegeneron Pharmaceuticals | Healthcare | 3.12% | $312.22 | 570 | $546K |
| 14 | GSKGSK | Healthcare | 2.51% | $250.63 | 8,900 | $438K |
| 15 | CRSPCRISPR Therapeutics AG | Healthcare | 1.92% | $191.55 | 8,342 | $335K |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | Eli Lilly & | 21.49% |
| 2 | ABBV | AbbVie | 10.16% |
| 3 | NVS | Novartis AG | 6.90% |
| 4 | JNJ | Johnson & Johnson | 6.05% |
| 5 | AMGN | Amgen | 4.88% |
| 6 | ALKS | Alkermes | 4.73% |
| 7 | AZN | AstraZeneca | 4.73% |
| 8 | MRK | Merck & | 4.35% |
| 9 | BMY | Bristol-Myers Squibb | 4.19% |
| 10 | BIIB | Biogen | 3.53% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 23, 2025 | Dec 24, 2025 | $0.41 |
| Dec 24, 2024 | Dec 26, 2024 | $0.51 |
| Dec 27, 2023 | Dec 29, 2023 | $1.64 |